Regeneron PharmaceuticalsREGN
Regeneron Pharmaceuticals 8-K
Filing date ·
Regeneron said that at its June 12, 2026 Annual Meeting of Shareholders, 5 Class II director nominees were elected to serve until the 2027 Annual Meeting of Sh…
Sign in to read this filing in detail
Continue to the filing details and any available analysis after signing in.
Filing lists are available without signing in.